Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Hansen (Frederiksberg, Denmark), O. Hilberg (Vejle, Denmark), C. Ulrik (Hvidovre, Denmark), M. Søndergaard (Copenhagen, Denmark), A. Von Bülow (Copenhagen, Denmark), A. Christiansen (Odense, Denmark), L. Rasmussen (Gentofte, Denmark), C. Johnsen (Gentofte, Denmark), J. Schmid (Aarhus, Denmark), A. Bjerrum (Aarhus, Denmark), A. Wimmer Aune (Aalborg, Denmark), K. Dahl Assing (Aalborg, Denmark), K. Rasmussen (Roskilde, Denmark), N. Krogh (Copenhagen, Denmark), C. Porsbjerg (Copenhagen, Denmark). Proportion of complete responders after one year of treatment with biologics for severe asthma - Results from the nationwide Danish Severe Asthma Register.. 2677

Member's Comments

No comment yet.

Related content which might interest you: COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry Source: Eur Respir J, 56 (6) 2002857; 10.1183/13993003.02857-2020 Year: 2020 Late Breaking Abstract - Preliminary analysis of the data of patients with severe bronchial asthma included in the Russian National Register of Severe Asthma (RSAR) Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts Year: 2019 Late Breaking Abstract - Characteristics of T2-biomarker low severe asthma patients in the UK Severe Asthma Registry (UKSAR) Source: International Congress 2019 – Asthma epidemiology in the 21st century Year: 2019 Swiss Severe Asthma Registry (SSAR)- Good asthma control and high number of exacerbations. How does this fit? Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 Triple combination therapy in severe asthma: overview from the Italian Registry Severe Asthma (IRSA) Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Characteristics of severe asthmatics treated with omalizumab, mepolizumab or no biotherapy. Data from the Belgian Severe Asthma Registry (BSAR). Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases Year: 2019 Effect of COPD medications on exacerbation rates in a real-life COPD patient cohort - data from the Czech Multicenter Research Database of COPD. Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Detection of asthma patient-reported exacerbations during follow-up in the ASTROLAB cohort Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 Mortality rates in individuals with asthma, COPD and ACOS in a large population-based cohort: Is gender important? Source: International Congress 2016 – Asthma, COPD, and ACOS: physical activity, dietary aspects, and diseases burden Year: 2016 Gender and its relation to asthma phenotype and comorbidities in difficult-to-control asthma patients from Czech National Severe Asthma Registry Source: Annual Congress 2008 - COPD epidemiology Year: 2008 Asthma medication during pregnancy: A cohort study in EFEMERIS database Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015 Causes of problematic asthma in children: Retrospective cohort study Source: Annual Congress 2013 –Uncontrolled and severe asthma in children Year: 2013 Trends in the asthma hospitalization rate in the Spanish pediatric population Source: Annual Congress 2013 –Uncontrolled and severe asthma in children Year: 2013 Characteristics of the frequent exacerbator in U-BIOPRED adult severe asthma cohort Source: International Congress 2015 – Phenotyping asthma with biomarkers Year: 2015 Clinical characteristics and burden of illness in a cohort of severe asthma patients Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life Year: 2016 Incidence and severity of acute exacerbations among women enrolled in an asthma management program during pregnancy: A prospective study of 1.283 pregnancies Source: International Congress 2016 – Best abstracts in asthma and COPD Year: 2016 BTS Difficult Asthma Registry: Effect of omalizumab dosing table expansion on size of population of severe persistent allergic asthma patients potentially eligible for omalizumab therapy Source: Annual Congress 2012 - Clinical diagnosis and treatment of adult asthma Year: 2012 Estimating severe asthma prevalence in austria using nationwide prescription data Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 Gender differences in patients with severe asthma in real-life setting: data from the Severe Asthma Network in Italy (SANI) registry Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 A national database study of the effectiveness of switching real-life asthma patients to fostair Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015